Skip to main content

Improving Colorectal Cancer Screening Rates

March 27, 2020

While multiple expert medical and scientific panels recommend colorectal cancer screening, one in three Americans between the ages of 50 and 75 have never been screened as recommended.  

Patients cite a number of reasons for not being tested:

  • Not receiving a doctor’s recommendation
  • Lack of screening options
  • Affordability concerns

While colonoscopy offers the advantage of polyp removal and biopsy, the invasiveness of the procedure, aversion to the preparation, inconvenience, and risk of complications can make this an unfavorable test for some patients.

Alternate Screening Options

High-sensitivity stool testing is a good alternative for patients who decline more invasive screening options. While these have their own set of pros and cons, they may be more acceptable to some of your reluctant patients:

  • Multiple randomized clinical trials have shown that screening with the guaiac-based fecal occult blood test (gFOBT) reduces colorectal cancer deaths  
  • Fecal immunochemical tests (FITs), which identify intact human hemoglobin in stool, have improved sensitivity compared with gFOBT for detecting colorectal cancer
  • Multitargeted stool DNA testing (FIT-DNA) combines a FIT with testing for altered DNA biomarkers in cells shed into the stool, and has increased single-test sensitivity for detecting colorectal cancer compared with FIT alone

Presenting multiple options for colorectal cancer screening to all adults, particularly for those with low income, has shown to increase likelihood of screening. A 2012 study found more patients complete screening when offered a choice of colonoscopy or stool test (69%) as compared to patients that are only offered colonoscopy (38%). The American Cancer Society found that unscreened patients are very responsive to messages indicating there are affordable take-home options available.   

To encourage average-risk patients over 50 to get screened, Quest Diagnostics® will send FIT kits directly to your practice. The kits are free and easy for patients to use at home, and do not require dietary or medication restrictions. Call 1-866-MY-QUEST to order a kit for your BlueCross BlueShield patients.

In the end, the best screening test is the one that patients actually agree to. Providing patients with all the screening options will help reduce colorectal cancer morbidity and mortality.

Recent Articles

  • Addressing Social Determinants of Health During COVID-19
    The COVID-19 pandemic is likely to further stress the social determinants of health (SDOH) that already affect the overall health and well-being of some of your patients. Here, we discuss how you can refer your BlueCross BlueShield patients in need into our care management program.
  • Integrating Postpartum Depression Screening at Child Well Visits
    As the COVID-19 pandemic continues, the changes associated with a new baby may be especially overwhelming for some of your patients. The AAP recommends that screening for postpartum depression (PPD) be conducted at child well visits every month for the first 6 months postpartum. Find out how your practice can integrate PPD screenings at child well visits.
  • Early-Onset Dementia and Alzheimer’s Disease Affecting Younger Americans
    A recent study conducted by the Blue Cross and Blue Shield Association and Blue Health Intelligence (BHI) shows that early-onset dementia and Alzheimer’s disease is increasingly impacting younger Americans. Here, we highlight the study’s findings and offer tools to help your patients.
  • CDC Recommendations on Shared Clinical Decision-Making
    When it comes to discussing vaccinations with your BlueCross BlueShield patients, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) suggests a shared provider and patient decision approach about the appropriateness of certain immunizations.
  • Protecting Patient Data: Cybersecurity Tips for Your Practice
    Cybersecurity is no longer an emerging concern, but a new reality within the health care industry. During this time of uncertainty, your information could be at risk by scammers sending false emails and phone calls/texts about COVID-19. BlueCross BlueShield Chief Information Security Officer Scott Morris outlines cybersecurity best practices you can use to mitigate security threats.

Working with Us

Additional Resources

We want to hear from you! Have a topic request for the next Blue Bulletin? Email us

Stay in Touch! Sign up to receive emails for provider news and information